This article was originally published in Start Up
PolyGenomics was spun-out of Yale University to develop a genetic amplification technology in the search for genes implicated in psychiatric illnesses.
You may also be interested in...
By 1994, functional genomics companies began forming to help a Big Pharma suddenly deluged by genomic data. Through the study of model genetic systems like nematodes and fruit flies, or homogenous peoples, these gene hunters hope to gain an understanding of how and when genes function--under normal conditions and in disease.
Oxagen's goal is to use large familial clinical groups and sample banks to identify disease genes through agreements with three groups of academic clinical investigators, located throughout Europe.
Since the mid-1950's getting "shots" has been a source of childhood terror. Now, small companies are looking at ways to deliver vaccines through the oral or nasal mucosa, or using needle-free skin delivery systems to take advantage of immune cells within the skin.